Advertisement
Advertisement

AURA

AURA logo

Aura Biosciences, Inc. Common Stock

8.02
USD
Sponsored
+0.09
+1.13%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

7.80

-0.22
-2.74%

Aura Biosciences, Inc. Common Stock Profile

About

Aura Biosciences Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system. The company's lead product candidate includes AU-011. Aura Biosciences Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Elisabet de los Pinos

Headquarters

80 GUEST STREET
BOSTON, MA 02135, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.aurabiosciences.com

Auditor

Ernst & Young LLP

Share holders

46

Employees

113

Aura Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

860.34M

Enterprise Value

775.54M

Enterprise Value/EBITDA(ttm)

-6.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.14

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-71.25%

Return on Invested Capital(ttm)

-72.30%

Return on Assets(ttm)

-59.06%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-117.51M

Net Income Available to Common(ttm)

-112.39M

Diluted EPS(ttm)

-1.79

Share Statistics

Beta (5Y Monthly)

0.35

52-Week Change

52.47%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

103.39M

Dividend Yield

0.00%

Float4

60.11M

% Held by Insiders

6.30%

% Held by Institutions

96.75%

Balance Sheet

Total Cash(mrq)

114.73M

Total Cash Per Share(mrq)

1.11

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.15%

Quick Ratio(mrq)

8.15%

Book Value Per Share(mrq)

2.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.40

Free Cash Flow(ytd)

-85.19M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement